<p class=”m-3444017640127977681msobodytext”>The draft recommendations are based on factors that have been found to support the success of national, community-based ePrescribing programmes internationally. HIQA’s <em>ePrescribing: an International Review</em> is published as a companion to this Draft for Consultation document and is available at <a href=”https://www.hiqa.ie/”>HIQA</a>.
<p class=”m-3444017640127977681msobodytext”> HIQA’s Director of Health Information and Standards, Rachel Flynn, said: “A national, community-based ePrescribing programme can deliver significant benefits for patients, prescribers and pharmacists. It can improve patient safety considerably by reducing cases of mistaken identity, incorrect dosage, incorrect medication and adverse drug interactions. ePrescribing can also save money and time compared to processing the same prescriptions manually.”
<p class=”m-3444017640127977681msobodytext”>The National ePrescribing Programme was announced at the first eHealth Ireland summit in June 2015. The recommendations published today will help drive the process forward.
<p class=”m-3444017640127977681msobodytext”>Ms Flynn continued: “HIQA is committed to stakeholder consultation and values all feedback provided to support the development of these ePrescribing recommendations. The consultation process will take place over a six-week period. In this way, the public, service users and service providers will have the opportunity to provide feedback and become involved in the future of ePrescribing in Ireland.”
<p class=”m-3444017640127977681msobodytext”>The closing date for receipt of comments is 5pm on Friday, 3 August 2018.
